Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients

SIMPLE SUMMARY: Melanoma patients who failed anti-PD-1 therapy have limited therapeutic options. Some studies suggested the efficacy of radiotherapy combined with anti-PD-1 monoclonal antibodies. We previously reported in small-sized studies that hypofractionated radiotherapy combined with an unmodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiag, Philippe, Molinier, Rafaele, Roger, Anissa, Boru, Blandine, Otmezguine, Yves, Otz, Joelle, Valery, Charles-Ambroise, Blom, Astrid, Longvert, Christine, Beauchet, Alain, Funck-Brentano, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454723/
https://www.ncbi.nlm.nih.gov/pubmed/36077606
http://dx.doi.org/10.3390/cancers14174069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454723/
https://www.ncbi.nlm.nih.gov/pubmed/36077606
http://dx.doi.org/10.3390/cancers14174069

Ejemplares similares